Recent Study: Slovakia Pharmaceuticals & Healthcare Report Q2 2014
Slovakia generally offers significant potential as a location for pharmaceutical research. This is thanks to its demographic and epidemiological profile, which is broadly similar to Western Europe; EU membership, which allows for faster regulatory filings and approvals; and relatively cheap production and labour costs. Austerity measures throughout the European Union precipitated a drive to cut pharmaceutical expenditure, with member states introducing price cuts and reference pricing to contain costs. We forecast further generic uptake and higher co-payments by patients, which...
View full press release